Literature DB >> 27873751

Rheumatoid vasculitis: early presentation of rheumatoid arthritis.

Yasir Abdulqader1, Muhsen Al-Ani2, Konstantinos Parperis3.   

Abstract

Rheumatoid vasculitis is a rare and late complication of rheumatoid arthritis and may affect small-to-medium-sized vessels. Here, we report a case of a 49-year-old man who presented with amaurosis fugax in the left eye, symmetric polyarthritis, Raynaud's symptoms and paraesthesia in both lower extremities. The patient subsequently experienced right foot drop, nail fold infracts and gangrene of his right second toe. He was found to have a high titre of rheumatoid factor and treatment with rituximab and high dose of corticosteroids led to significant improvement of his symptoms. This is rare case describing the early onset of rheumatoid vasculitis in a patient with rheumatoid arthritis. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 27873751      PMCID: PMC5129099          DOI: 10.1136/bcr-2016-217557

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  21 in total

1.  Association of HLA-C3 and smoking with vasculitis in patients with rheumatoid arthritis.

Authors:  Carl Turesson; Daniel J Schaid; Cornelia M Weyand; Lennart T Jacobsson; Jörg J Goronzy; Ingemar F Petersson; Sonja A Dechant; Britt-Marie Nyähll-Wåhlin; Lennart Truedsson; Gunnar Sturfelt; Eric L Matteson
Journal:  Arthritis Rheum       Date:  2006-09

2.  Expansion of unusual CD4+ T cells in severe rheumatoid arthritis.

Authors:  P B Martens; J J Goronzy; D Schaid; C M Weyand
Journal:  Arthritis Rheum       Date:  1997-06

3.  CD56-expressing T cells that have features of senescence are expanded in rheumatoid arthritis.

Authors:  Joshua J Michel; Carl Turesson; Bonnie Lemster; Sarah R Atkins; Cristina Iclozan; Tim Bongartz; Mary Chester Wasko; Eric L Matteson; Abbe N Vallejo
Journal:  Arthritis Rheum       Date:  2007-01

4.  Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases.

Authors:  D G Scott; P A Bacon; C R Tribe
Journal:  Medicine (Baltimore)       Date:  1981-07       Impact factor: 1.889

5.  Particular HLA-DRB1 shared epitope genotypes are strongly associated with rheumatoid vasculitis.

Authors:  Jennifer D Gorman; Eve David-Vaudey; Madhukar Pai; Raymond F Lum; Lindsey A Criswell
Journal:  Arthritis Rheum       Date:  2004-11

6.  IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy.

Authors:  D G Scott; P A Bacon; C Allen; C J Elson; T Wallington
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

Review 7.  Management of extra-articular disease manifestations in rheumatoid arthritis.

Authors:  Carl Turesson; Eric L Matteson
Journal:  Curr Opin Rheumatol       Date:  2004-05       Impact factor: 5.006

8.  The mortality of rheumatoid vasculitis compared with rheumatoid arthritis.

Authors:  A E Voskuyl; A H Zwinderman; M L Westedt; J P Vandenbroucke; F C Breedveld; J M Hazes
Journal:  Arthritis Rheum       Date:  1996-02

Review 9.  Rheumatoid vasculitis: experience with 13 patients and review of the literature.

Authors:  H A Schneider; R A Yonker; P Katz; S Longley; R S Panush
Journal:  Semin Arthritis Rheum       Date:  1985-05       Impact factor: 5.532

10.  Central nervous system involvement as a major manifestation of rheumatoid arthritis.

Authors:  M Zolcinski; S Bazan-Socha; G Zwolinska; J Musial
Journal:  Rheumatol Int       Date:  2007-08-10       Impact factor: 2.631

View more
  2 in total

1.  Tocilizumab-induced granulomatous vasculitis and cutaneous actinomycosis in a patient with rheumatoid arthritis.

Authors:  Justyna Ziandarska; Magdalena Górecka-Sokołowska; Rafał Czajkowski
Journal:  Postepy Dermatol Alergol       Date:  2022-09-01       Impact factor: 1.664

2.  Nursing intervention reduces depression for patients with rheumatoid arthritis: A randomized controlled trial protocol.

Authors:  Moying Liu; Baoxin Shi
Journal:  Medicine (Baltimore)       Date:  2020-11-20       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.